Form 8-K - Current report:
SEC Accession No. 0000950170-25-015501
Filing Date
2025-02-06
Accepted
2025-02-06 17:05:45
Documents
11
Period of Report
2025-02-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K tern-20250201.htm   iXBRL 8-K 45399
  Complete submission text file 0000950170-25-015501.txt   167638

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tern-20250201.xsd EX-101.SCH 26983
13 EXTRACTED XBRL INSTANCE DOCUMENT tern-20250201_htm.xml XML 5119
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39926 | Film No.: 25598305
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)